The Clinical Management of the Parotid Masses: A Five Year Study
|
|
|
- Augusta Barnett
- 10 years ago
- Views:
Transcription
1 İstanbul Tıp Derg - Istanbul Med J 2012;13(3): doi: / ORIGINAL ARTICLE - KLİNİK ÇALIŞMA The Clinical Management of the Parotid Masses: A Five Year Study Parotis Kitlelerine Klinik Yaklaşım: 5 Yıllık Deneyim Suat BİLİCİ, Meltem Esen AKPINAR, Özgür YİĞİT, Zehra DÖNMEZ SUMMARY Objectives: Our objective was to analyze the diagnostic measures and management methods for benign and malignant lesions localized in the parotid gland and to assess the role of radiological imaging, fine-needle aspiration biopsy (FNAB), the type and extent of surgery in respect to histopathology of the lesion and subsequent functional results. Methods: The data related to 79 parotidectomies performed in our clinic between October 2005 and December 2010 were retrospectively reviewed. Age, gender, clinical findings, FNAB cytology, radiological evaluation, surgical methods, histopathological evaluation, and complications were recorded. Results: The distribution of the lesions found on the 79 patients was as follows: 59 benign (75%), 19 malignant (24%), and one inflammatory (1%). The most common benign tumor was pleomorphic adenoma (69%) and the most common malignant tumor was acinic cell carcinoma (15.8%). The mean age of patients with malignant tumor was significantly higher than the mean age of patients with benign tumors. The accuracy rate of FNAB was 90.63% for malignant tumors and 76.56% for benign tumors. The 37 pleomorphic adenomas localized in the superficial lobe and the 13 Warthin s tumors were managed with superficial parotidectomy, whereas the 12 malignant and 5 benign tumors localized in the deep lobe were removed with total parotidectomy. The most common complication in our series was facial paralysis (5%). Conclusion: Despite the significant contribution of FNAB cytology, particularly in malignant-benign differentiation, the diagnosis of parotid gland lesions should include either clinical or radiological data as complementary to FNAB cytology data. Ultrasonography, owing to the low cost and absence of radiation exposure, may be used routinely for locating superficial lobe masses. CT and MRI may be reserved for malignant and selected benign cases. Our surgical preference was superficial parotidectomy in superficial benign parotid masses and total parotidectomy in deep-lobe benign tumors and advanced-stage malignant tumors. Key words: Fine-needle aspiration biopsy; parotidectomy; parotid tumor. ÖZET Amaç: Bu çalışmada, parotis bezinde yerleşmiş benign ve malign lezyonların tanı yöntemleri ve tedavi metodları, radyolojik görüntüleme ve ince iğne aspirasyon biopsisinin (İİAB) lezyonun histopatolojik tanısını desteklemede ve yapılacak cerrahinin şeklini belirlemedeki rolü ve fonksiyonel sonuçlar değerlendirildi. Gereç ve Yöntem: Ekim 2005 ile Aralık 2010 tarihleri arasında kliniğimizde yapılan 79 parotidektomi retrospektif olarak tarandı. Yaş, cinsiyet, klinik bulgular, İİAB sitolojisi, radyolojik değerlendirme, cerrahi metodlar, histopatolojik değerlendirme ve komplikasyonlar kaydedildi. Bulgular: Yetmiş dokuz hastanın lezyon dağılımı; 59 benign (%75), 19 malign (%24) ve 1 enflamatuvardı (%1). En yaygın benign tümör pleomorfik adenom (%69), en yaygın malign tümör asinik hücreli karsinomdu (%15.8). Malign tümörlü hastaların ortalama yaşı benign tümörlü hastaların yaşına göre anlamlı olarak yüksekti. İİAB nin doğruluk oranı malign tümörler için %90.63, benign tümörler için %76.56 idi. Yüzeyel lobta yerleşik 37 pleomorfik adenom ve 13 Warthin tümörüne superfisiyal parotidektomi yapılırken, derin lobta yerleşmiş 12 malign ve 5 benign tümör total parotidektomi ile çıkarılmıştır. Serimizde en yaygın komplikasyon fasiyal paraliziydi (%5). Sonuç: İİAB sitolojisinin malign benign ayırımındaki belirgin ayırıcılığına rağmen, parotis bezi lezyonlarının tanısı radyolojik ve klinik verilerin İİAB verilerini tamamlaması ile konur. Ultrasonografi ucuz maliyeti ve radyasyon riskinin olmaması ile yüzeyel lob lezyonlarında rutin olarak kullanılır. Bilgisayarlı tomografi ve manyetik rezonans görüntüleme malign ve bazı seçici benign lezyonlarda tercih edilir. Cerrahi tercihimiz süperfisiyal lob benign tümörlerde superfisiyal parotidektomi iken derin lob benign tümörlerde ve ileri evre malign tümörlerde total parotidektomidir. Anahtar sözcükler: İnce iğne aspirasyon biopsisi; parotidektomi; parotis tümörü. Submitted (Geliş tarihi): Accepted (Kabul tarihi): İstanbul Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Kliniği, İstanbul Correspondence (İletişim): Dr. Suat Bilici. (e-posta): [email protected] 125
2 İstanbul Tıp Derg INTRODUCTION The management of parotid masses including diagnostic and therapuetic aspects warrants systematical approach. In diagnostic work-up apart form the history, the radiological imaging techniques including ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) are frequently encountered. [1] Fine-needle aspiration biopsy (FNAB) is of value in benign and malignant differentiation. The accuracy rate of FNAB in benign and malignant lesion differentiation was reported as 81-98%. [2,3] In another study, the validity of FNAB was found nearly 80%. [3,4] The major complications associated with fine-needle aspiration biopsy were not reported previously. FNAB is an easy, safe, and minimally invasive procedure. [4-6] In parotid masses, the combined data derived from clinical, radiological and pathological assessment provides the final diagnosis. [7] Seventy to eighty percent of all salivary gland tumors are localized in parotid gland. Parotid masses are predominantly benign tumors (80%). The most commonly encountered benign tumors are pleomorphic adenomas, followed by Warthin s tumor. The most common malignant tumor of the parotid gland is mucoepidermoid carcinoma. [8] Benign lesions localized in the superficial lobe are managed with superficial parotidectomy, whereas benign lesions localized in the deep lobe necessitate total parotidectomy. [9,10] In the early stages, superficial malignant lesions also only require superficial parotidectomy; however, total parotidectomy is performed for deep lobe lesions. In advanced stages and for high grade lesions, neck dissection and/or radiotherapy are combined with total parotidectomy. [8] In this study, 79 patients diagnosed with parotid tumors were retrospectively analyzed. The clinical findings, fine-needle aspiration biopsy results, type of the surgery, postoperative histopathology, and any resulting complications. The diagnostic measures were reviewed to assess the role of radiological imaging and FNAB. The management including the type and extent of surgical treatment was discussed Table 1. Classification of cytology Positive value Negative value Positive value Negative value Exclusively benign lesion Malignant, inflammatory, or suspicious Exclusively malignant lesion Malignant, inflammatory, or suspicious in respect to histopathology of the lesion and subsequent functional results. MATERIALS AND METHODS This study retrospectively analyzed 79 patients who received operations for parotid masses and metastatic lesions at the Istanbul Training and Research Hospital between 2005 and The demographic, clinical, surgical, histopathological and postoperative follow-up data. Postoperative complications, malignant tumor stages for malignant lesions and data were collected from their records. The demographic data included age, gender. Clinical data consisted of symptoms, signs, staging for malignant lesions, signs revealed through clinical examination and radiologi- Table 2. Histopathology of the parotid tumors (October 2005-December 2010) Histology n % Benign tumors Pleomorphic adenoma Warthin s tumor Myoepithelioma 2 Oncocytoma 1 Lymphoepitalial cyst 1 Malignant tumors Acinic cell carcinoma 3 Mucoepidermoid carcinoma 2 Adenoid cystic carcinoma 2 Epidermoid carcinoma 2 Malignant fibrous histiocytoma 1 Spindle cell carcinoma 1 Myoepitelial carcinoma 1 Auricula basal cell carcinoma 1 Retromolar trigone epidermoid carcinoma 1 Salivary duct carcinoma 1 Folliculer lymphoma 1 Buccal region epidermoid carcinoma 1 Undiferantiated pleomorphic sarcoma 1 Inflammatory parotid disease
3 The Clinical Management of the Parotid Masses: A Five Year Study Table 3. Comparison of benign and malignant parotid tumors Benign Malignant No. of patients Male / Female 35/25 12/6 Age (year) 47.9 (18-82) 64.6 (28-86) Right/Left/Bilateral 32/27/1 10/8 Superficial/Deep/Safe 55/5 6/9/3 cal imaging. Surgical data included type of surgery, perioperative findings, histopathological data consisted of FNAB cytology and final specimen pathology reports. FNAB cytology was categorized (Table 1) to calculate specificity, sensitivity, and accuracy values were also calculated. The statistical analysis was performed using SAS package (9.2 version, cary, NC, USA). A student t- test was used to compare categorical data on benign and malignant lesions. The predictive value of fineneedle aspiration biopsy in the diagnosis of benign and malignant tumors was calculated using a chisquare test. RESULTS Seventy-nine patients had a parotidectomy at the Istanbul Training and Research Hospital Second Otolaryngology Clinic between 2005 and Postoperative histological diagnoses are summarized in Table 2. Table 5. Radiological imaging (BT and MRI) Patient groups BT MRI BT+MRI Malignant Malignant fibrous histiocytoma + Retromolar trigone epidermoid carcinoma + Spindle cell carcinoma + İndiferantiated anaplastic carcinoma + Pleomorphic undiferantiated sarcoma + Myoepitelial carcinoma + Renal clear cell carcinoma metastasis + Benign Giant pleomorphic adenoma + Pleomorphic adenoma recurrence + The male and female distribution was 48 (61%) and 31 (39%), respectively. The distribution of patients with benign lesions is summarized in Table 3. The average age for patients with benign and malignant lesions was 47.9 and 64 years old, respectively. The difference between the two groups was statistically significant (p=0.0002) (Table 4). Pleomorphic adenoma (69%) was the most commonly encountered benign lesion, with the second most common lesion being Warthin s tumor (23%). The Warthin s tumor was bilateral in one patient out of 14. In our series, the most common malignant tumors were acinic cell carcinoma (15.8%), mucoepidermoid carcinoma (10.5%), adenoid cystic carcinoma (10.5%), and epidermoid carcinoma (10.5%), respectively. Sixty-one superficial and 15 deep- lobe localized tumors were encountered. The distribution is summarized in Table 3. Radiological Evaluation During the diagnostic work-up, every patient had an ultrasonographical examination. The distribution of selected patients with CT and MRI exams during the preoperative diagnostic work-up is summarized in Table 5. Table 4. Comparison of age and gender in the benign and malignant parotid tumors (p<0.05) n Avarage Standard deviation p Age All groups Benign Malignant Gender (Male/Female) All groups 47/ /0.403 Benign 35/ / Malignant 12/ /
4 İstanbul Tıp Derg Table 6. The patient distribution according to FNAB results Cytology Histology Total Benign Malignant Inflammation Not available Benign Malignant Inflammation Suspicious Not available Total Fine-Needle Aspiration Biopsy (FNAB) Cytology: FNAB was performed in 64 of 79 patients. Five of the remaining 15 patient had neighboring metastatic lesions with incisional biopsy results. Ten patient had their biopsy performed in other centres and had no records at our institution. FNAB was consistent with the final diagnosis in 33 of 41 patients diagnosed with pleomorphic adenoma. The records of five patients were missing. The remaining patients were reported as having chronic inflammation (1 case), intraparotid neoplasia (1 case), and spindle cell neoplasia (1 case). The FNAB was consistent with the final diagnosis of Warthin s tumors in seven of 14 patients. In the remaining five patients, FNAB was revealed acute inflammation (1 case), suspicious cytology (1 case), oncocytic epithelial cells (1 case) and cyst consistent findings (1 case). In three cases with a final diagnosis of acinic cell carcinoma, FNAB revealed a benign oncocytic tumor, suspicious cytology, and was inconclusive in discrimination between mucoepidermoid carcinoma and benign epithelial tumors. In this study, the specificity, sensitivity, and accuracy of FNAB for malignant tumors was calculated as 0.98, 0.58 and 0.91, respectively. FNAB specificity, sensitivity and accuracy for benign tumors were calculated as 0.58, 0.81, and 0.77, respectively (Tables 6,7,8). Surgical Procedure and Evaluation of Results Thirthy-seven pleomorphic adenoma (59.6%) and 13 Warthin s tumors (20%) were diagnosed in 62 patients undergoing superficial parotidectomy. Our surgical approach was a classical superficial parotidectomy, involving a preauriculocervical incision (Blair), and the detection of the main trunk of the facial nerve with through an anterograde approach. Facial nerve monitorization was not routine, except revision surgeries. One of the 62 patients with the basal cell carcinoma of the auricula had a superficial parotidectomy together with a skin excision, and another patient with the final diagnosis of Warthin s tumor had a superficial parotidectomy together with a skin excision and functional neck dissection. A total parotidectomy was performed in one recurrent case, FNAB reported pleomorphic adenoma with a final histopathological diagnosis of epidermoid carcinoma. Three patients with maxillar skin epidermoid Table 7. Specificity, sensitivity and accuracy of the FNAB for malignant parotid tumors Cytology Histology Total Positive Negative Positive Negative Total Specificity= 51/52= ; Sensitivity= 7/12= ; Accuracy= 58/64= Table 8. Specificity, sensitivity and accuracy of the FNAB for benign parotid tumors Cytology Histology Total Positive Negative Positive Negative Total Specificity= 7/12= ; Sensitivity= 42/52= ; Accuracy= 49 /64=
5 The Clinical Management of the Parotid Masses: A Five Year Study Table 9. The cases without recurrence following radiotherapy Malignant tumor cases n Asinic cell carcinoma 3 Mucoepidermoid carcinoma 2 Adenoid cystic carcinoma 2 Salivary duct carcinoma 1 Spindle cell sarcoma 1 Myoepitelial carcinoma 1 Table 10. Complications following parotidectomy Benign Malignant Facial nerve paralysis 2 2 Transient facial nerve paralysis 1 0 Frey s syndrome 2 1 Seroma 1 0 Wound hematoma 1 1 Salivary fistula 1 0 carcinoma, basal cell auricular carcinoma, and retromolar trigone carcinoma had a superficial parotidectomy combined with an excision of the original lesion, but a histopathological parotid gland infiltration was not detected. Seventeen patients with 12 malignant and five benign lesions had a total parotidectomy. Seven patient had a neck dissection (two radical, one modified radical, and four functional) combined with a total parotidectomy. Deep -lobe localized pleomorphic adenomas (4 cases) and Warthin s tumor (1 case) were managed with a total parotidectomy. Two patients with a histopathological diagnosis of follicular lymphoma and malign fibrous histiocytoma had chemotherapy. One patient with malignant fibrous histiocytoma had a recurrence, and one patient with a tumor in retromolar trigone had a recurrence despite postoperative radiotheraphy and chemotherapy. The patients with parotid gland metastasis of renal clear cell carcinoma (1 case), epidermoid carcinoma (1 case), pleomorphic undifferentiated sarcoma (1 case) died. Malignant cases without recurrence in follow-ups after parotidectomy and radiotherapy were summarized in Table 9. Evaluation of Complications Transient peripheral facial paralysis arising in a patient following a superficial parotidectomy recovered after three months. Patients with facial paralysis were evaluated using the Hause-Brackman grading system. Facial paralysis was encountered following two superficial parotidectomies for benign tumors and two total parotidectomies for malignant tumors (5%). The evaluation of postoperative complications revealed Frey s syndrome (3 cases), hematoma (2 cases), salivary fistula (1 case), and seroma (1 case) (Table 10). DISCUSSION In our series, the routinely ordered radiological imaging was US in patients suspected of benign tumor. Recently various imaging techniques have been proposed for the preoperative evaluation of parotid lesions including ultrasonography, CT and MRI (2 cases). In deep- lobe tumors with a tendency for infiltration, tumor recurrences, and facial paralysis, CT and MRI are important tools for making diagnoses in conjunction with US (3 cases). Owing to its high sensitivity and better differentiation of soft tissues, MRI is a better choice than CT. [11] Advanced stage malignant tumors are differentiated from benign tumors with irreguler features, infiltration, and a lack of differentiation from subdermal tissues (4 cases). [12] MRI was performed on adjacent tumors with the possibility of infiltrating parotis tissue, and on metastatic tumors. US was primarily ordered radiological evaluation, whereas CT and MRI were reserved for selected cases. The significance of fine-needle aspiration biopsy in preoperative evaluations of parotid tumors is controversial. In a previous study, the accuracy of malignant and benign parotid tumors was found to be between 81 and 98%. [2] In another study, the accuracy was reported as 80-90%. [13] Karaman et al. [14] observed the overall diagnostic accuracy of FNAB in parotid gland lesions was %. The diagnostic sensitivity and specificity were % and 100%, respectively. In our study, the accuracy of FNAB was found 90.63% and 76.56% in benign and malig- 129
6 İstanbul Tıp Derg nant tumors, respectively, and was concordant with the previous data. The sensitivity and specificity of FNAB was detected as 58% and 98% in malignant lesion and 81% and 58% in benign lesions. The detected ratios seem to be supportive for the diagnostic value of FNAB. [13,15] The routine or selective use of FNA for parotid masses is still under discussion and the standards for performing FNA in parotid masses are not clearly established. [15] In our series, FNAB was performed on all patients with a detected mass in the parotid gland mainly to identify the parotid lesions indicating surgical intervention. Concordant with previous literature, we did not encounter any major FNAB-related complications. [16,17] Pleomorphic adenoma is most commonly encountered benign parotid tumor. In the present series, the pleomorphic adenoma was the most common benign tumor (52%), followed by Warthin s tumor (17.7%). In a previous study from Singapore, the most common benign parotid tumor was reported as Warthin s (40%). The same series reported 36% pleomorphic adenoma. [18] Geographical and genetic differences may play role in the etiology. In many previous studies, a significantly high incidence of Warthin s tumor was reported in men, compared to women. [19] In the present series, all patients diagnosed with Warthin s tumor are male, and this prevalance can be explained by the higher smoking rate in males, provoking metaplasia. [19-23] Mucoepidermoid carcinoma was reported as the most common malignant tumor of parotid glands in previous studies. [24-27] Al-Khateeb et al have reported a similar incidence of mucoepidermoid carcinoma and adenoid cystic carcinoma. [28] Another study of 478 cases reported the most common malignant tumor to be acinic cell carcinoma. [29] In the present series, the distribution of 14 patient with primary malignant tumors revealed acinic cell carcinoma (3 cases) and mucoepidermoid carcinoma (2 cases) as the most commonly encountered malignant tumors. The most common surgical procedure was a superficial parotidectomy. Benign tumors localized in the superficial lobe of the parotid gland and early stage malignant tumors of the superficial lobe were managed with a superfical parotidectomy. The previous studies reported high recurrence ratios (4-40%) with tumor enucleation and conservative parotidectomy. [9,10] However there are recent reports emphasizing the role of partial superficial parotidectomy in providing more cosmetic and the functional results. [30] The presence of malignant tumors necessitates the use of combination therapy. Superficial parotidectomy is adequate for the management of earlystage and low-grade tumors. In the present series, eight patient with superficial lobe-localized malignant tumors had a superficial parotidectomy. A total parotidectomy was performed on deep-lobe tumors. Radiotherapy and/or chemotheraphy were included according to the histopathological evalution of tumors. In advanced -stage parotid lesions, a total parotidectomy was combined with neck dissection and radiotherapy. In the present series, seven patients with advanced-stage malignant tumors had a neck dissection and radiotherapy, and one had chemotherapy. The tail is the most common localization of parotid tumors. The marginal mandibular nerve is the most commonly injured branch, due to its long course and to facial nerve. [31,32] Revison surgery and a history of infection statistically increase the incidence of facial paralysis, which was reported as 5% in our series and 4.9% in a previous study. [33] Frey s syndrome was reported in a wide range, from 5-66%, in the literature. [34,35] In the present series, we encountered three cases (3.7%) of Frey s syndrome. CONCLUSION Despite the significant contribution of FNAB cytology particularly in malignant-benign differentiation, the diagnosis of parotid gland lesions should include either clinical and radiological data as complementary to FNAB cytology data. US may be used routinely for locating benign lesions. CT and MRI may be reserved for malignant and selected benign cases. Our surgical preference was superficial parotidectomy in superficial benign parotid masses whereas total parotidectomy in deep-lobe benign tumors 130
7 The Clinical Management of the Parotid Masses: A Five Year Study and advanced-stage malignant tumors. REFERENCES 1. Urquhart A, Hutchins LG, Berg RL. Preoperative computed tomography scans for parotid tumor evaluation. Laryngoscope 2001;111: Seethala RR, LiVolsi VA, Baloch ZW. Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck 2005;27: Howlett DC. Diagnosing a parotid lump: fine needle aspiration cytology or core biopsy? Br J Radiol 2006;79: Zbären P, Nuyens M, Loosli H, et al. Diagnostic accuracy of fine-needle aspiration cytology and frozen section in primary parotid carcinoma. Cancer 2004;100: Herrera Hernández AA, Díaz Pérez JA, García CA, et al. Evaluation of fine needle aspiration cytology in the diagnosis of cancer of the parotid gland. [Article in Spanish] Acta Otorrinolaringol Esp 2008;59: [Abstract] 6. Salgarelli AC, Capparè P, Bellini P, et al. Usefulness of fine-needle aspiration in parotid diagnostics. Oral Maxillofac Surg 2009;13: Bussu F, Parrilla C, Rizzo D, et al. Clinical approach and treatment of benign and malignant parotid masses, personal experience. Acta Otorhinolaryngol Ital 2011;31: Lin CC, Tsai MH, Huang CC, et al. Parotid tumors: a 10-year experience. Am J Otolaryngol 2008;29: Bradley PJ. Pleomorphic salivary adenoma of the parotid gland: which operation to perform? Curr Opin Otolaryngol Head Neck Surg 2004;12: Zbären P, Tschumi I, Nuyens M, et al. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg 2005;189: Lee YY, Wong KT, King AD, et al. Imaging of salivary gland tumours. Eur J Radiol 2008;66: Harish K. Management of primary malignant epithelial parotid tumors. Surg Oncol 2004;13: Cohen EG, Patel SG, Lin O, et al. Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population. Arch Otolaryngol Head Neck Surg 2004;130: Karaman M, Tuncel A, Tel A, Erdem Habeşoğlu T. Correlation between fine needle aspiration biopsy and histologic findings in parotid masses. KBB ve BBC Dergisi 2010;18: Zbären P, Schär C, Hotz MA, et al. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope 2001;111: Awan MS, Ahmad Z. Diagnostic value of fine needle aspiration cytology in parotid tumors. J Pak Med Assoc 2004;54: Aversa S, Ondolo C, Bollito E, et al. Preoperative cytology in the management of parotid neoplasms. Am J Otolaryngol 2006;27: Lim LH, Chao SS, Goh CH, et al. Parotid gland surgery: 4-year review of 118 cases in an Asian population. Head Neck 2003;25: Yoo GH, Eisele DW, Askin FB, et al. Warthin s tumor: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope 1994;104: Chung YF, Khoo ML, Heng MK, et al. Epidemiology of Warthin s tumour of the parotid gland in an Asian population. Br J Surg 1999;86: Eveson JW, Cawson RA. Warthin s tumor (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases. Oral Surg Oral Med Oral Pathol 1986;61: Seifert G, Donath K. Multiple tumours of the salivary glands--terminology and nomenclature. Eur J Cancer B Oral Oncol 1996;32: Batsakis JG, el-naggar AK. Warthin s tumor. Ann Otol Rhinol Laryngol 1990;99: Li LJ, Li Y, Wen YM, et al. Clinical analysis of salivary gland tumor cases in West China in past 50 years. Oral Oncol 2008;44: Subhashraj K. Salivary gland tumors: a single institution experience in India. Br J Oral Maxillofac Surg 2008;46: Vargas PA, Gerhard R, Araújo Filho VJ, et al. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo 2002;57: Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999;120: Al-Khateeb TH, Ababneh KT. Salivary tumors in north Jordanians: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103: van der Wal JE, Leverstein H, Snow GB, et al. Parotid gland tumors: histologic reevaluation and reclassification of 478 cases. Head Neck 1998;20: Roh JL, Kim HS, Park CI. Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy. Br J Surg 2007;94: Al Salamah SM, Khalid K, Khan IA, et al. Outcome of surgery for parotid tumours: 5-year experience of a general surgical unit in a teaching hospital. ANZ J Surg 2005;75: Astor FC, Ackerman EB, Hanft KL, et al. Surgical 131
8 İstanbul Tıp Derg treatment of parotid tumors in the general community hospital. South Med J 2002;95: Granell J, Sánchez-Jara JL, Gavilanes J, et al. Management of the surgical pathology of the parotid gland: A review of 54 cases. [Article in Spanish] Acta Otorrinolaringol Esp 2010;61: [Abstract] 34. Guntinas-Lichius O, Klussmann JP, Wittekindt C, et al. Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope 2006;116: Marshall AH, Quraishi SM, Bradley PJ. Patients perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol 2003;117:
DEEP LOBE PAROTIDECTOMY OF PLEOMORPHIC ADENOMA WHICH PRESENTED AS A SUPERFICIAL PAROTID MASS
DEEP LOBE PAROTIDECTOMY OF PLEOMORPHIC ADENOMA WHICH PRESENTED AS A SUPERFICIAL PAROTID MASS YÜZEYEL PAROTİS KİTLESİ İLE PREZENTE OLAN PLEOMORFİK ADENOMA DERİN LOB PAROTİDEKTOMİ Baş Boyun Cerrahisi Başvuru:
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
OBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.
Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)
Cigarette Smoking and Warthin's Tumor
American Journal of Epidemiology Copyright C 1996 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 144, No. 2 Printed In USA A BRIEF ORIGINAL CONTRIBUTION Cigarette
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
Medullary Renal Cell Carcinoma Case Report
Bahrain Medical Bulletin, Vol. 27, No. 4, December 2005 Medullary Renal Cell Carcinoma Case Report Mohammed Abdulla Al-Tantawi MBBCH, CABS* Abdul Amir Issa MBBCH, CABS*** Mohammed Abdulla MBBCH, CABS**
Pediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
Recommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
Salivary Gland Cancer
What is cancer? Salivary Gland Cancer The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly way. During the early years of a person s
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15
MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer
Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11
Nicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
BRAF in the diagnostic evaluation of thyroid nodules
Symposium 13 Molecular markers in thyroid cancer: current role in clinical practice BRAF in the diagnostic evaluation of thyroid nodules Laura Fugazzola University of Milan, Italy Papillary carcinoma BRAF
Histopathology of Major Salivary Gland Neoplasms
Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department
Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease
International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
Lung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach
Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation
Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
Four Important Facts about Kidney Cancer
Volume Article.13-11 Publish Date: 24th June 2013 Author(s): MPUH - CRS Team Four Important Facts about Kidney Cancer ARTICLE hhh Muljibhai Patel Urological Hospital (MPUH) Centre For Robotic Surgery (CRS)
Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD
Thyroid Fine-Needle Aspiration Indications and Technique Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD Thyroid FNA Indication Clinical Thyroid Nodule (s) > 1 cm? Hypo-functioning
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)
The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
YOUR LUNG CANCER PATHOLOGY REPORT
UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7
Provider Reimbursement for Women's Cancer Screening Program
Reimbursement Schedule July 1, 2015 June 30, 2016 Office Visits - Established Patients Office Visit / Minimal / no physician 99211 $ 16.70 Office Visit / Problem focused History / exam 99212 $ 36.46 Preventive
Primary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.
This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:
Classificazioni citologiche: verso uno schema internazionale unificato?
Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi Diagnostic categories
Learning about Mouth Cancer
Learning about Mouth Cancer Creation of this material was made possible in part by a pioneering grant from CBCC-USA. Distributed by India Cancer Initiative What is mouth cancer? Our bodies are made up
SMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Saturation Biopsy for Diagnosis and Staging of Prostate Cancer. Original Policy Date
MP 7.01.101 Saturation Biopsy for Diagnosis and Staging of Prostate Cancer Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date /12/2013 Return to Medical Policy
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid
Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid
GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE
Genomics in Medicine Series GENETICS AND GENOMICS OF THYROID NEOPLASMS MOVING CLOSER TOWARDS PERSONALIZED PATIENT CARE Electron Kebebew, MD, FACS Outline To assess the change in thyroid cancer epidemiology
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
Understanding Your Surgical Options For Breast Cancer
RADIATION THERAPY SYMPTOM MANAGEMENT CANCER INFORMATION Understanding Your Surgical Options For Breast Cancer In this booklet you will learn about: Role of surgery in breast cancer diagnosis and treatment
Surgical Treatment of Chronic Rhinosinusitis in. Children
Surgical Treatment of Chronic Rhinosinusitis in Children Fuad M. Baroody, M.D., F.A.C.S. Professor of Otolaryngology-Head and Neck Surgery and Pediatrics The University of Chicago Medicine and Biological
LIVER CANCER AND TUMOURS
LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood
Diagnosis and Treatment of Common Oral Lesions Causing Pain
Diagnosis and Treatment of Common Oral Lesions Causing Pain John D. McDowell, DDS, MS University of Colorado School of Dentistry Chair, Oral Diagnosis, Medicine and Radiology Director, Oral Medicine and
Early Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Integumentary System Individual Exercises
Integumentary System Individual Exercises 1. A physician performs an incision and drainage of a subcutaneous abscess in his office for a particularly uncooperative established patient. How should this
Frozen Section Diagnosis
Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD With the widespread use of cross-sectional imaging, many renal masses are incidentally found. These need to be accurately
Differences in type of comorbidity and complications in young and elderly
Differences in type of comorbidity and complications in young and elderly 5.1 Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer Peters TTA
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); [email protected] Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
A Retrospective Review of Treatment of the Odontogenic Keratocyst
A Retrospective Review of Treatment of the Odontogenic Keratocyst J Oral Maxillofac Surg 63:635-639, 2005 Teresa A. Morgan, DDS, MS,* Christopher C. Burton, DDS, MS, and Fang Qian, MA, PhD Purpose: The
Skin cancer Patient information
Skin cancer Patient information What is cancer? The human body is made up of billions of cells. In healthy people, cells grow, divide and die. New cells constantly replace old ones in an orderly way. This
Adult tonsillectomy: relationship between indications and postoperative hemorrhage
BEHBUT CEVANŞİR KULAK BURUN BOĞAZ HASTALIKLARI.. VE BAŞ BOYUN CERRAHİSİ DERNEĞİ Kulak Burun Bogaz Ihtis Derg 2012;22(1):21-25 Original Article / Çalışma - Araştırma doi: 10.5606/kbbihtisas.2012.004 21
Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla
Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy
Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules
Multiple Primary and Histology Site Specific Coding Rules KIDNEY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
www.downstatesurgery.org
Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills
Guidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
Chapter 13. The hospital-based cancer registry
Chapter 13. The hospital-based cancer registry J.L. Young California Tumor Registry, 1812 14th Street, Suite 200, Sacramento, CA 95814, USA Introduction The purposes of a hospital-based cancer registry
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.
PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition [email protected] September 23, 2010 Screening: 3 tests for PCa A good screening
Lip Cancer: Treatment & Reconstruction
Lip Cancer: Treatment & Reconstruction GBMC - Head & Neck Cancer Grand Rounds Elizabeth E. Redd, M.D. With the assistance of Ira Papel, M.D. Patrick Byrne, M.D. Lip Cancer: Treatment & Reconstruction Anatomic
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
An Update on Lung Cancer Diagnosis
An Update on Lung Cancer Diagnosis Dr Michael Fanning MBBS FRACGP FRACP RESPIRATORY AND SLEEP PHYSICIAN Mater Medical Centre Outline Risk factors for lung cancer Screening for lung cancer Radiologic follow-up
Common Breast Complaints:
: Palpable mass Abnormal mammogram with normal physical exam Vague thickening or nodularity Nipple Discharge Breast pain Breast infection or inflammation The physician s goal is to determine whether the
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women
Mesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
General Information About Non-Small Cell Lung Cancer
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS This is a patient information booklet providing specific practical information about gall bladder polyps in brief. Its aim is to provide the patient
Neoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
Molecular Markers in Fine Needle Aspirates of the Thyroid
Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL
Oncoplastic breast conservation surgery Melvin J Silverstein C H A P T E R 5 Introduction Oncoplastic breast conservation surgery combines oncologic principles with plastic surgical techniques. But it
Guide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
PSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Small cell lung cancer
Small cell lung cancer Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing organs that are found within
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
Molecular Diagnostics in Thyroid Cancer
Disclosure Nothing to disclose Jonathan George, MD, MPH Assistant Professor Head and Neck Oncologic & Endocrine Surgery Molecular Diagnostics in Thyroid Cancer Current Practices & Future Trends UCSF Medical
Historical Basis for Concern
Androgens After : Are We Ready? Mohit Khera, MD, MBA Assistant Professor of Urology Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Historical
Surgical guidelines for the management of breast cancer
Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...
Molecular Pathogenesis of Thyroid Cancer
Introduction Thyroid cancer is the fastest growing cancer diagnosis in the US [1, 2] with a total of 44,670 new cases and 1,690 deaths expected in 2010 (www.cancer.gov/cancertopics/types/thyroid). From
Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010
Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict
